BDBM83327 MLS000389417::N-(4-fluorophenyl)-2-[(6-methyl-1H-benzimidazol-2-yl)sulfanyl]-2-phenyl-ethanamide::N-(4-fluorophenyl)-2-[(6-methyl-1H-benzimidazol-2-yl)sulfanyl]-2-phenylacetamide::N-(4-fluorophenyl)-2-[(6-methyl-1H-benzimidazol-2-yl)thio]-2-phenyl-acetamide::N-(4-fluorophenyl)-2-[(6-methyl-1H-benzimidazol-2-yl)thio]-2-phenylacetamide::SMR000255690::cid_5211364

SMILES Cc1ccc(O)c(C)c1-n1c(N)c(C(N)=O)c2cnc(N3CC[C@@H](O)C3)nc21

InChI Key InChIKey=FZUUMOITZDSEMQ-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 83327   

TargetMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase(Human)
The Scripps Research Institute Molecular Screening Center

Curated by PubChem BioAssay
LigandChemical structure of BindingDB Monomer ID 83327BDBM83327(US20250388583, Compound 583)
Affinity DataIC50: 50nMAssay Description:Keywords: apoptosis, BH3 domain, Bcl2-A1, BIM, caspase, cancer Primary Collaborator: Todd Golub, Broad Institute, golub@broadinstitute.org Assay Over...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/6/2026
Entry Details
US Patent